Kazanov D - Search Results

1

Celecoxib and curcumin additively inhibit the growth of colorectal cancer in a rat model.

Shpitz B, Giladi N, Sagiv E, Lev-Ari S, Liberman E, Kazanov D, Arber N. Shpitz B, et al. Among authors: kazanov d. Digestion. 2006;74(3-4):140-4. doi: 10.1159/000098655. Epub 2007 Jan 15. Digestion. 2006. PMID: 17228149

2

Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.

Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N. Lev-Ari S, et al. Among authors: kazanov d. Clin Cancer Res. 2005 Sep 15;11(18):6738-44. doi: 10.1158/1078-0432.CCR-05-0171. Clin Cancer Res. 2005. PMID: 16166455

3

Malignant transformation of normal enterocytes following downregulation of Bak expression.

Liberman E, Naumov I, Kazanov D, Dvory-Sobol H, Sagiv E, Birkenfeld S, Deutsch V, Trakhtenbrot L, Moshkowitz M, Arber N. Liberman E, et al. Among authors: kazanov d. Digestion. 2008;77(1):48-56. doi: 10.1159/000121411. Epub 2008 Mar 18. Digestion. 2008. PMID: 18349538

4

Curcumin potentiates the pro-apoptotic effects of sulindac sulfone in colorectal cancer.

Giladi N, Kazanov D, Shpitz B, Aroch I, Kraus S, Arber N. Giladi N, et al. Among authors: kazanov d. Expert Opin Investig Drugs. 2010 Apr;19 Suppl 1:S117-24. doi: 10.1517/13543781003718841. Expert Opin Investig Drugs. 2010. PMID: 20374023

5

Gene expression following exposure to celecoxib in humans: pathways of inflammation and carcinogenesis are activated in tumors but not normal tissues.

Sagiv E, Sheffer M, Kazanov D, Shapira S, Naumov I, Kraus S, Domany E, Arber N. Sagiv E, et al. Among authors: kazanov d. Digestion. 2011;84(3):169-84. doi: 10.1159/000322688. Epub 2011 May 5. Digestion. 2011. PMID: 21546775

6

Celecoxib but not rofecoxib inhibits the growth of transformed cells in vitro.

Kazanov D, Dvory-Sobol H, Pick M, Liberman E, Strier L, Choen-Noyman E, Deutsch V, Kunik T, Arber N. Kazanov D, et al. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):267-71. doi: 10.1158/1078-0432.ccr-0412-3. Clin Cancer Res. 2004. PMID: 14734479

7

Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.

Dvory-Sobol H, Sagiv E, Liberman E, Kazanov D, Arber N. Dvory-Sobol H, et al. Among authors: kazanov d. Cancer. 2007 Jan 15;109(2):188-97. doi: 10.1002/cncr.22416. Cancer. 2007. PMID: 17149756 Free article.

8

Gene expression analysis proposes alternative pathways for the mechanism by which celecoxib selectively inhibits the growth of transformed but not normal enterocytes.

Sagiv E, Rozovski U, Kazanov D, Liberman E, Arber N. Sagiv E, et al. Among authors: kazanov d. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6807-15. doi: 10.1158/1078-0432.CCR-07-1091. Clin Cancer Res. 2007. PMID: 18006783

9

MF tricyclic and sulindac retard tumor formation in an animal model.

Dvory-Sobol H, Kazanov D, Liberman E, Birkenfeld S, Bulvik B, Luk P, Leshno M, Arber N. Dvory-Sobol H, et al. Among authors: kazanov d. Int J Cancer. 2006 Jan 1;118(1):11-6. doi: 10.1002/ijc.21218. Int J Cancer. 2006. PMID: 16003752

10

CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis.

Sagiv E, Memeo L, Karin A, Kazanov D, Jacob-Hirsch J, Mansukhani M, Rechavi G, Hibshoosh H, Arber N. Sagiv E, et al. Among authors: kazanov d. Gastroenterology. 2006 Aug;131(2):630-9. doi: 10.1053/j.gastro.2006.04.028. Gastroenterology. 2006. PMID: 16890615

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters